Socid Friendly Socid Friendly
Arama Sonuçları
Tüm Sonuçları Gör
  • Katıl
    Giriş yapın
    Başvur
    Site içinde arama yapın
    Night Mode

Site içinde arama yapın

Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek

  • Web sayfası bildirimcisi
  • EXPLORE
  • Sayfalar
  • Gruplar
  • Events
  • Blogs
  • Marketplace
  • Offers
  • Jobs
  • Forums
  • Oyunlar
  • Developers
  • Yazı
  • Articles
  • Kullanıcılar
  • Sayfalar
  • Gruplar
  • Events
  • Deepak Patle bir dosya eklendi Other
    2026-03-12 11:12:24
    Clinical Oncology Next Generation Sequencing Market Trends, Precision Oncology Growth, and Forecast 2033
    Clinical Oncology Next Generation Sequencing Industry Insights: Straits Research recently introduced the latest update on the Clinical Oncology Next Generation Sequencing Market that provides an extensive outlook of the market, analyzing key growth opportunities, challenges, risk factors, and emerging trends across diverse geographic regions. The report offers a definitive and meticulous...
    0 Yorumlar 0 hisse senetleri 1273 Views
    Please log in to like, share and comment!
  • Subhayan Mayra bir dosya eklendi Other
    2026-04-18 10:04:55
    Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034
    According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...
    0 Yorumlar 0 hisse senetleri 105 Views
    Please log in to like, share and comment!
  • Subhayan Mayra bir dosya eklendi Other
    2026-04-13 12:28:25
    Global Selpercatinib Capsules Market Growing at 7.8% CAGR Through 2034
    According to a new report from Intel Market Research, the global Selpercatinib Capsules market was valued at USD 420 million in 2025 and is projected to reach USD 820 million by 2034, growing at a CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of RET-altered cancers, growing adoption of biomarker-driven therapies, and...
    0 Yorumlar 0 hisse senetleri 638 Views
    Please log in to like, share and comment!
© 2026 Socid Friendly Turkish
English Indonesia Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
About Brand Game Online Koşullar Gizlilik Contact Us Rehber